cacodylic acid has been researched along with Acute Promyelocytic Leukemia in 7 studies
dimethylarsinic acid : The organoarsenic compound that is arsenic acid substituted on the central arsenic atom with two methyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Arsenic has been used successfully in clinical trials for treating acute promyelocytic leukemia (APL)." | 9.11 | Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment. ( Gong, Z; Le, XC; Lu, X; Wang, Z; Zhou, J, 2004) |
| "Arsenic trioxide (ATO) has been successfully applied in the treatment of acute promyelocytic leukemia (APL)." | 8.02 | Monomethylated arsenic was the Major methylated arsenic in Red blood cells of acute promyelocytic leukemia patients treated with arsenic trioxide. ( Chen, H; Gao, C; Gao, Y; Guo, M; Guo, S; Hai, X; Lin, L; Wang, X; Wu, Z, 2021) |
| "Arsenic trioxide (ATO) is widely applied to treat acute promyelocytic leukemia (APL)." | 7.91 | Time course of arsenic species in red blood cells of acute promyelocytic leukemia (APL) patients treated with single agent arsenic trioxide. ( Fan, S; Gao, C; Guo, M; Hai, X; Hu, S; Liu, S; Wang, B; Wang, W; Zhou, J, 2019) |
| "Arsenic trioxide (As2O3) effectively induces complete clinical and molecular remissions in acute promyelocytic leukemia (APL) patients and triggers apoptosis in APL cells." | 7.80 | Metabolism of arsenic trioxide in acute promyelocytic leukemia cells. ( Ahmadian, S; Alimoghaddam, K; Ghaffari, SH; Ghavamzadeh, A; Khaleghian, A, 2014) |
| "Arsenic trioxide has been successfully used as a therapeutic in the treatment of acute promyelocytic leukemia (APL)." | 7.79 | Arsenic speciation in saliva of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment. ( Cao, F; Chen, B; Le, XC; Lu, X; Shen, S; Yuan, C; Zhou, J, 2013) |
| "Arsenic has been used successfully in clinical trials for treating acute promyelocytic leukemia (APL)." | 5.11 | Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment. ( Gong, Z; Le, XC; Lu, X; Wang, Z; Zhou, J, 2004) |
| "Arsenic trioxide (ATO) has been successfully applied in the treatment of acute promyelocytic leukemia (APL)." | 4.02 | Monomethylated arsenic was the Major methylated arsenic in Red blood cells of acute promyelocytic leukemia patients treated with arsenic trioxide. ( Chen, H; Gao, C; Gao, Y; Guo, M; Guo, S; Hai, X; Lin, L; Wang, X; Wu, Z, 2021) |
| "Arsenic trioxide (ATO) is widely applied to treat acute promyelocytic leukemia (APL)." | 3.91 | Time course of arsenic species in red blood cells of acute promyelocytic leukemia (APL) patients treated with single agent arsenic trioxide. ( Fan, S; Gao, C; Guo, M; Hai, X; Hu, S; Liu, S; Wang, B; Wang, W; Zhou, J, 2019) |
| "Arsenic trioxide (As(III) in solution) has been shown to be the most active single agent in combating acute promyelocytic leukemia (APL)." | 3.83 | Exceptions in patterns of arsenic compounds in urine of acute promyelocytic leukaemia patients treated with As2O3. ( Černelč, P; Falnoga, I; Podgornik, H; Šlejkovec, Z, 2016) |
| "Arsenic trioxide (As2O3) is one of the most effective therapeutic agents used for patients with acute promyelocytic leukemia (APL)." | 3.81 | Methylated arsenic metabolites bind to PML protein but do not induce cellular differentiation and PML-RARα protein degradation. ( Bu, N; Cao, FL; Naranmandura, H; Wang, QQ; Zhang, YF; Zhou, J; Zhou, XY, 2015) |
| "Arsenic trioxide (As2O3) effectively induces complete clinical and molecular remissions in acute promyelocytic leukemia (APL) patients and triggers apoptosis in APL cells." | 3.80 | Metabolism of arsenic trioxide in acute promyelocytic leukemia cells. ( Ahmadian, S; Alimoghaddam, K; Ghaffari, SH; Ghavamzadeh, A; Khaleghian, A, 2014) |
| "Arsenic trioxide has been successfully used as a therapeutic in the treatment of acute promyelocytic leukemia (APL)." | 3.79 | Arsenic speciation in saliva of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment. ( Cao, F; Chen, B; Le, XC; Lu, X; Shen, S; Yuan, C; Zhou, J, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, S | 1 |
| Wang, X | 1 |
| Gao, C | 2 |
| Wu, Z | 1 |
| Chen, H | 1 |
| Lin, L | 1 |
| Guo, M | 2 |
| Gao, Y | 1 |
| Hai, X | 2 |
| Wang, B | 1 |
| Liu, S | 1 |
| Wang, W | 1 |
| Hu, S | 1 |
| Fan, S | 1 |
| Zhou, J | 4 |
| Khaleghian, A | 1 |
| Ghaffari, SH | 1 |
| Ahmadian, S | 1 |
| Alimoghaddam, K | 1 |
| Ghavamzadeh, A | 1 |
| Wang, QQ | 1 |
| Zhou, XY | 1 |
| Zhang, YF | 1 |
| Bu, N | 1 |
| Cao, FL | 1 |
| Naranmandura, H | 1 |
| Šlejkovec, Z | 1 |
| Podgornik, H | 1 |
| Černelč, P | 1 |
| Falnoga, I | 1 |
| Chen, B | 1 |
| Cao, F | 1 |
| Yuan, C | 1 |
| Lu, X | 2 |
| Shen, S | 1 |
| Le, XC | 2 |
| Wang, Z | 1 |
| Gong, Z | 1 |
1 trial available for cacodylic acid and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.
Topics: Adult; Antineoplastic Agents; Arsenic; Arsenic Trioxide; Arsenicals; Arsenites; Cacodylic Acid; Chro | 2004 |
6 other studies available for cacodylic acid and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
Monomethylated arsenic was the Major methylated arsenic in Red blood cells of acute promyelocytic leukemia patients treated with arsenic trioxide.
Topics: Adolescent; Adult; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Biotransformation; Cacodylic | 2021 |
Time course of arsenic species in red blood cells of acute promyelocytic leukemia (APL) patients treated with single agent arsenic trioxide.
Topics: Adult; Aged; Antineoplastic Agents; Arsenic; Arsenic Trioxide; Arsenicals; Cacodylic Acid; Child; Ch | 2019 |
Metabolism of arsenic trioxide in acute promyelocytic leukemia cells.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cacodylic Acid; Cell Line, Tumor; DN | 2014 |
Methylated arsenic metabolites bind to PML protein but do not induce cellular differentiation and PML-RARα protein degradation.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Biotransformation; Cacodylic Acid; C | 2015 |
Exceptions in patterns of arsenic compounds in urine of acute promyelocytic leukaemia patients treated with As2O3.
Topics: Adult; Arsenic Trioxide; Arsenicals; Cacodylic Acid; Female; Humans; Inactivation, Metabolic; Leukem | 2016 |
Arsenic speciation in saliva of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.
Topics: Adult; Antineoplastic Agents; Arsenates; Arsenic Trioxide; Arsenicals; Arsenites; Cacodylic Acid; Ch | 2013 |